Anticoagulant and thrombolytic drugs. I. Patho-physiological and pharmacological aspects

Drugs. 1971;1(3):228-46. doi: 10.2165/00003495-197101030-00003.
No abstract available

Publication types

  • Review

MeSH terms

  • Aminocaproates / pharmacology
  • Anticoagulants / administration & dosage
  • Anticoagulants / antagonists & inhibitors
  • Anticoagulants / pharmacology
  • Anticoagulants / therapeutic use*
  • Antifibrinolytic Agents
  • Blood Coagulation / drug effects
  • Blood Platelets / drug effects
  • Coumarins / administration & dosage
  • Coumarins / antagonists & inhibitors
  • Coumarins / pharmacology
  • Cyclohexanecarboxylic Acids / pharmacology
  • Dipyridamole / pharmacology
  • Ethylestrenol / pharmacology
  • Factor XII
  • Factor XIII
  • Fibrin / pharmacology
  • Fibrinogen
  • Fibrinolysin / pharmacology
  • Fibrinolytic Agents / administration & dosage
  • Fibrinolytic Agents / pharmacology*
  • Fibrinolytic Agents / therapeutic use*
  • Heparin / administration & dosage
  • Heparin / pharmacology
  • Heparin Antagonists
  • Humans
  • Indenes / pharmacology
  • Peptide Hydrolases / adverse effects
  • Peptides / pharmacology
  • Phenformin / pharmacology
  • Plasminogen / pharmacology
  • Protamines / pharmacology
  • Streptokinase / pharmacology
  • Thrombin
  • Thromboembolism / drug therapy*
  • Thromboembolism / etiology
  • Vitamin K / pharmacology

Substances

  • Aminocaproates
  • Anticoagulants
  • Antifibrinolytic Agents
  • Coumarins
  • Cyclohexanecarboxylic Acids
  • Fibrinolytic Agents
  • Heparin Antagonists
  • Indenes
  • Peptides
  • Protamines
  • Vitamin K
  • Dipyridamole
  • Factor XII
  • Fibrin
  • Fibrinogen
  • Plasminogen
  • Heparin
  • Factor XIII
  • Ethylestrenol
  • Phenformin
  • Peptide Hydrolases
  • Streptokinase
  • Thrombin
  • Fibrinolysin